Opaleye Management Inc. 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Opaleye Management Inc. | 3,171,800 4.940% |
171,400 (+5.71%) |
Filing |
| 2020-09-18 6:48 pm Purchase |
2020-09-09 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Opaleye Management Inc. | 3,000,400 5.100% |
3,000,400 (New Position) |
Filing |